392 related articles for article (PubMed ID: 27118356)
1. Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.
Wildes TM; Campagnaro E
J Geriatr Oncol; 2017 Jan; 8(1):1-7. PubMed ID: 27118356
[TBL] [Abstract][Full Text] [Related]
2. Optimizing quality of life in multiple myeloma patients: current options, challenges and recommendations.
Maes H; Delforge M
Expert Rev Hematol; 2015 Jun; 8(3):355-66. PubMed ID: 25739703
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Frailty Scores in Newly Diagnosed Patients with Multiple Myeloma: A Review.
Mian H; Brouwers M; Kouroukis CT; Wildes TM
J Frailty Aging; 2019; 8(4):215-221. PubMed ID: 31637409
[TBL] [Abstract][Full Text] [Related]
4. Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper.
Grant SJ; Mian HS; Giri S; Boutin M; Dottorini L; Neuendorff NR; Krok-Schoen JL; Nikita N; Rosko AE; Wildes TM; Zweegman S
J Geriatr Oncol; 2021 May; 12(4):499-507. PubMed ID: 33342724
[TBL] [Abstract][Full Text] [Related]
5. Concise review - Treatment of multiple myeloma in the very elderly: How do novel agents fit in?
Kint N; Delforge M
J Geriatr Oncol; 2016 Sep; 7(5):383-9. PubMed ID: 27567255
[TBL] [Abstract][Full Text] [Related]
6. Characterize, Optimize, and Harmonize: Caring for Older Adults With Hematologic Malignancies.
Wildes TM; Artz AS
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-9. PubMed ID: 33979197
[TBL] [Abstract][Full Text] [Related]
7. A comparison of three different approaches to defining frailty in older patients with multiple myeloma.
Isaacs A; Fiala M; Tuchman S; Wildes TM
J Geriatr Oncol; 2020 Mar; 11(2):311-315. PubMed ID: 31326393
[TBL] [Abstract][Full Text] [Related]
8. Determining treatment intensity in elderly patients with multiple myeloma.
Salvini M; D'Agostino M; Bonello F; Boccadoro M; Bringhen S
Expert Rev Anticancer Ther; 2018 Sep; 18(9):917-930. PubMed ID: 29972740
[TBL] [Abstract][Full Text] [Related]
9. Elderly patients with multiple myeloma: towards a frailty approach?
Zweegman S; Engelhardt M; Larocca A;
Curr Opin Oncol; 2017 Sep; 29(5):315-321. PubMed ID: 28763310
[TBL] [Abstract][Full Text] [Related]
10. Geriatric assessments and frailty scores in multiple myeloma patients: a needed tool for individualized treatment?
Möller MD; Gengenbach L; Graziani G; Greil C; Wäsch R; Engelhardt M
Curr Opin Oncol; 2021 Nov; 33(6):648-657. PubMed ID: 34534141
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of dose-attenuated bortezomib, cyclophosphamide and dexamethasone ("VCD-Lite") in very old or otherwise toxicity-vulnerable adults with newly diagnosed multiple myeloma.
Tuchman SA; Moore JO; DeCastro CD; Li Z; Sellars E; Kang Y; Long G; Gasparetto CG
J Geriatr Oncol; 2017 May; 8(3):165-169. PubMed ID: 28256432
[TBL] [Abstract][Full Text] [Related]
12. Treatment of older adult or frail patients with multiple myeloma.
Grant SJ; Freeman CL; Rosko AE
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):46-54. PubMed ID: 34889397
[TBL] [Abstract][Full Text] [Related]
13. Management of Newly Diagnosed Elderly Multiple Myeloma Patients.
Antoine-Pepeljugoski C; Braunstein MJ
Curr Oncol Rep; 2019 May; 21(7):64. PubMed ID: 31127403
[TBL] [Abstract][Full Text] [Related]
14. Multiple myeloma in the older adult: better prospects, more challenges.
Wildes TM; Rosko A; Tuchman SA
J Clin Oncol; 2014 Aug; 32(24):2531-40. PubMed ID: 25071143
[TBL] [Abstract][Full Text] [Related]
15. Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis.
Salazar AS; Recinos LM; Mian HS; Stoll C; Simon LE; Sekhon S; Colditz GA; Wildes TM
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):488-496.e6. PubMed ID: 31133527
[TBL] [Abstract][Full Text] [Related]
16. Managing multiple myeloma in elderly patients.
Diamond E; Lahoud OB; Landau H
Leuk Lymphoma; 2018 Jun; 59(6):1300-1311. PubMed ID: 28847191
[TBL] [Abstract][Full Text] [Related]
17. Multiple myeloma: Current and future management in the aging population.
Fotiou D; Ntanasis-Stathopoulos I; Gavriatopoulou M; Dimopoulos MA
Maturitas; 2020 Aug; 138():8-13. PubMed ID: 32631590
[TBL] [Abstract][Full Text] [Related]
18. Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplant.
Rosko AE; Huang Y; Benson DM; Efebera YA; Hofmeister C; Jaglowski S; Devine S; Bhatt G; Wildes TM; Dyko A; Jones D; Naughton MJ; Byrd JC; Burd CE
J Geriatr Oncol; 2019 May; 10(3):479-485. PubMed ID: 29983352
[TBL] [Abstract][Full Text] [Related]
19. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report.
Palumbo A; Bringhen S; Mateos MV; Larocca A; Facon T; Kumar SK; Offidani M; McCarthy P; Evangelista A; Lonial S; Zweegman S; Musto P; Terpos E; Belch A; Hajek R; Ludwig H; Stewart AK; Moreau P; Anderson K; Einsele H; Durie BG; Dimopoulos MA; Landgren O; San Miguel JF; Richardson P; Sonneveld P; Rajkumar SV
Blood; 2015 Mar; 125(13):2068-74. PubMed ID: 25628469
[TBL] [Abstract][Full Text] [Related]
20. How should older adults with cancer be evaluated for frailty?
Huisingh-Scheetz M; Walston J
J Geriatr Oncol; 2017 Jan; 8(1):8-15. PubMed ID: 27318797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
